ArticleJournal of nanobiotechnology2025

M2-ApoBDs as a therapeutic strategy for systemic lupus erythematosus: targeted macrophage reprogramming and treg differentiation.

Juan Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.